image

The best stocks to buy since 1993

Latest issue now available

Mpac

February 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • MPAC
  • Price:
  • 377.5p
GP3 constituent MPAC, to which we added during last year’s sell off, soared during the month after confirming that with supply chains easing, H2 played catchup and full year performance will now be in line. ShoreCap forecasts £6.9m pretax profit for eps of 26.3p for the year ended in December. As Chief executive Adam Holland explains, Mpac’s individual contracts tend to be lumpy - at say £2m-£5m - and Mpac generates the majority of its revenue through contracts to design, engineer and construct high-specification automation and secondary packaging lines, with contracts in a normal environment delivered over a period of 9-15 months. But FY22 through to H1 23 had presented challenges; logistics and supply chains froze and it ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe